Bristol-Myers Unit Seeks To Revive Blood Thinner Patent
A subsidiary of Bristol-Myers Squibb urged an appeals court on Wednesday to restore its patent for a blockbuster blood thinner, arguing that an earlier judge applied the wrong test when deciding...To view the full article, register now.
Already a subscriber? Click here to view full article